Androgenetic Alopecia: An Evidence-Based Treatment Update

被引:151
作者
Varothai, Supenya [1 ,2 ]
Bergfeld, Wilma F. [2 ]
机构
[1] Mahidol Univ, Fac Med, Dept Dermatol, Siriraj Hosp, Bangkok 10700, Thailand
[2] Cleveland Clin, Dermatol & Plast Surg Inst, Dept Dermatol, Cleveland, OH 44195 USA
关键词
PATTERN HAIR LOSS; PLATELET-RICH PLASMA; DOUBLE-BLIND; 5-ALPHA-REDUCTASE INHIBITORS; 5-PERCENT MINOXIDIL; CYPROTERONE-ACETATE; TOPICAL APPLICATION; CLINICAL-TRIAL; FINASTERIDE; GROWTH;
D O I
10.1007/s40257-014-0077-5
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Androgenetic alopecia (AGA) is one of the most common chronic problems seen by dermatologists worldwide. It is characterized by progressive hair loss, especially of scalp hair, and has distinctive patterns of loss in women versus men, but in both genders the central scalp is most severely affected. It often begins around puberty and is known to effect self-esteem and the individual's quality of life. In contrast to the high prevalence of AGA, approved therapeutic options are limited. In addition to the scarce pharmacologic treatments, there are numerous nonprescription products claimed to be effective in restoring hair in androgenetic alopecia. Objectives The purpose of this paper is to review published medical and non-medical treatments for male and female AGA using the American College of Physicians evidence assessment methods. MEDLINE, EMBASE and Cochrane Library were searched for systematic reviews, randomized controlled trials, open studies, case reports and relevant studies of the treatment of male and female AGA. The relevant articles were classified according to grade and level of evidence. Results The medical treatments with the best level of evidence classification for efficacy and safety for male AGA are oral finasteride and topical minoxidil solution. For female AGA, topical minoxidil solution appears to be the most effective and safe treatment. The medical treatments corresponding to the next level of evidence quality are some commonly used therapeutic non-FDA-approved options including oral and topical anti-hormonal treatments. Surgical treatment of follicular unit hair transplantation is an option in cases that have failed medical treatment although there is high variation in outcomes. Limitations Some articles, especially those concerning traditional herbs claimed to promote hair regrowth, were published in non-English, local journals. Conclusions An assessment of the evidence quality of current publications indicates that oral finasteride (for men only) and topical minoxidil (for men and women) are the best treatments of AGA.
引用
收藏
页码:217 / 230
页数:14
相关论文
共 111 条
  • [1] Hair regrowth in a male patient with extensive androgenetic alopecia on estrogen therapy
    Adenuga, Paul
    Summers, Pamela
    Bergfeld, Wilma
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (03) : E121 - E122
  • [2] Avram Marc R, 2007, J Cosmet Laser Ther, V9, P27, DOI 10.1080/14764170601134479
  • [3] Pattern Hair Loss in Men Diagnosis and Medical Treatment
    Banka, Nusrat M. D.
    Bunagan, M. J. Kristine
    Shapiro, Jerry
    [J]. DERMATOLOGIC CLINICS, 2013, 31 (01) : 129 - +
  • [4] TOPICAL TRETINOIN FOR HAIR-GROWTH PROMOTION
    BAZZANO, GS
    TEREZAKIS, N
    GALEN, W
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1986, 15 (04) : 880 - &
  • [5] The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial
    Berger, RS
    Fu, JL
    Smiles, KA
    Turner, CB
    Schnell, BM
    Werchowski, KM
    Lammers, KM
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (02) : 354 - 362
  • [6] Bergstrom KG, 2011, J DRUGS DERMATOL, V10, P98
  • [7] Male Breast Cancer and 5α-Reductase Inhibitors Finasteride and Dutasteride
    Bird, Steven T.
    Brophy, James M.
    Hartzema, Abraham G.
    Delaney, Joseph A. C.
    Etminan, Mahyar
    [J]. JOURNAL OF UROLOGY, 2013, 190 (05) : 1811 - 1814
  • [8] A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia
    Blume-Peytavi, Ulrike
    Loennfors, Sanna
    Hillmann, Kathrin
    Bartels, Natalie Garcia
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (05) : 794 - 800
  • [9] A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women
    Blume-Peytavi, Ulrike
    Hillmann, Kathrin
    Dietz, Ekkehart
    Canfield, Douglas
    Bartels, Natalie Garcia
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 65 (06) : 1126 - 1134
  • [10] Blume-Peytavi Ulrike, 2007, J Dtsch Dermatol Ges, V5, P391, DOI 10.1111/j.1610-0387.2007.06295.x